Module 7A drug selectively prevents L-type Ca²⁺ channels fro…
Module 7A drug selectively prevents L-type Ca²⁺ channels from opening in ventricular contractile cells. Pacemaker and conducting cells remain functional.Explain the normal role of Ca²⁺ influx in the plateau phase of a contractile-cell action potential. (5 points)Predict how blocking these channels will change the action potential and refractory period. (5 points)Predict the effects on contraction strength, stroke volume, and cardiac output. (6 points)Explain why the heart may continue generating a regular electrical rhythm even though its pumping ability is impaired. (4 points)